Follicular, Mantle Cell and Hodgkin Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma

Featuring perspectives from Dr Jeremy S Abramson, Dr Stephen M Ansell, Dr Nancy L Bartlett, Dr Jonathon B Cohen, Dr Jonathan W Friedberg and Dr Brad S Kahl, including the following topics: Introduction (0:00) Evolving Role of Novel Treatment Strategies in Follicular Lymphoma (FL) — Dr Friedberg (7:20) Integration of CAR (Chimeric Antigen Receptor) T-Cell Therapies and Bispecific Antibodies into the Management of FL — Dr Abramson (33:08) Up-Front Treatment for Mantle Cell Lymphoma (MCL) — Dr Kahl (58:54) Therapeutic Sequencing for Patients with Relapsed/Refractory (R/R) MCL — Dr Cohen (1:23:46) First-Line Treatment Strategies for Hodgkin Lymphoma (HL) — Dr Bartlett (1:45:42) Current and Future Management of R/R HL — Dr Ansell (2:18:49) CME information and select publications